Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application symbols : Acer save search
Acer Therapeutics Receives Notice of Allowance of Key US Patent Application Covering EDSIVO™ (celiprolol)Notice of allowance of celiprolol method of treatment of vEDS patent application strengthens proprietary position in U.S. until 2038
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -0.81%
H: 5.57%
C: 3.28%
treatment patent application celiprolol therapeutics
Acer Therapeutics Receives Notice of Allowance of Key US Patent Application Covering EDSIVO™ (celiprolol)
Published: 2022-10-26 (Crawled : 12:20) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -0.81%
H: 5.57%
C: 3.28%
patent application therapeutics
Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate
Published: 2022-10-03 (Crawled : 13:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -23.08%
H: 42.86%
C: 30.95%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 2.88%
H: 1.4%
C: -0.35%
patent application therapeutics
Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs
Published: 2022-07-18 (Crawled : 13:20) - biospace.com/
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 4.3%
H: 1.87%
C: 0.0%
acer-001 treatment drug application resubmission therapeutics
Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
Published: 2022-06-21 (Crawled : 16:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -21.33%
H: 27.12%
C: 14.41%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -15.91%
H: 8.65%
C: 8.65%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -10.23%
H: 0.0%
C: 0.0%
acer-001 fda drug application therapeutics review update
Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 FormulationNotice of allowance of ACER-001 formulation composition of matter patent application strengthens proprietary position in U.S. until 2036
Published: 2021-10-07 (Crawled : 13:00) - biospace.com/
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -5.1%
H: 4.29%
C: -4.43%
patent application
Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation
Published: 2021-10-07 (Crawled : 13:00) - acertx.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -5.1%
H: 4.29%
C: -4.43%
patent application
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.